NeoGenomics (NASDAQ:NEO) Trading Down 7.7% After Analyst Dow

NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) shares dropped 7.7% on Tuesday after Needham & Company LLC lowered their price target on the stock from $24.00 to $19.00. Needham & Company LLC currently has a buy rating on the stock. NeoGenomics traded as low as $13.70 and last traded at $14.05. Approximately 252,873 shares changed […]

Related Keywords

United States , United Kingdom , Aliciac Olivo , William Blair , Piper Sandler , Goldman Sachs Group , Neogenomics Inc , Nasdaq , Financial Services Group Inc , Clinical Services , Securities Exchange Commission , Bluepath Capital Management , Quadrant Capital Group , Needham Company , Burkett Financial Services , Get Free Report , General Counsel Alicia , Exchange Commission , Path Capital Management , Financial Services , Capital Group , Services Group , Genomics Trading Down , Advanced Diagnostics , Neogenomics Daily ,